| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.07 |